Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
US Department of Justice
Colorcon
AstraZeneca
Federal Trade Commission
Citi
Johnson and Johnson
Boehringer Ingelheim
Healthtrust

Generated: December 12, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: oxycodone

« Back to Dashboard

oxycodone

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090 NDA Collegium Pharmaceutical, Inc. 24510-110-10 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24510-110-10)
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090 NDA Collegium Pharmaceutical, Inc. 24510-110-20 20 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (24510-110-20)
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090 NDA Collegium Pharmaceutical, Inc. 24510-115-10 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24510-115-10)
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090 NDA Collegium Pharmaceutical, Inc. 24510-115-20 20 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (24510-115-20)
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090 NDA Collegium Pharmaceutical, Inc. 24510-120-10 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24510-120-10)
Collegium Pharm Inc XTAMPZA ER oxycodone CAPSULE, EXTENDED RELEASE;ORAL 208090 NDA Collegium Pharmaceutical, Inc. 24510-120-20 20 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (24510-120-20)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Accenture
Johnson and Johnson
Citi
Daiichi Sankyo
Queensland Health
AstraZeneca
McKinsey
Boehringer Ingelheim